Ambu has appointed Scott Heinzelman as president of its North America commercial region, effective immediately.

Abbott (NYSE: ABT) announced today that it received CE mark for its Esprit BTK everolimus-eluting resorbable scaffold system.

ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...

The FDA issued a notice outlining a serious recall of the Boston Scientific (NYSE:BSX) carotid WallStent monorail ...

Terumo announced today that it entered into a definitive agreement to acquire OrganOx and its organ preservation technology.

Otsuka Medical Devices announced that Japanese authorities approved the Recor Medical Paradise ultrasound renal denervation ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Novocure announced today that it submitted an FDA premarket approval (PMA) application for its tumor-treating fields therapy.

Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners ...

CMR Surgical announced today that it appointed Chris O'Hara to its new role of commercial president & GM in the U.S.

Solventum (NYSE:SOLV) today announced that it commenced offers to purchase outstanding notes for up to $1.75 billion.

E (Nasdaq:NVNO) announced today that it received a not-approvable letter from the FDA related to its VenoValve.